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4 In vitro characteristics
of the SCGM-system
4.1 Introduction
Variouscharacteristics of a glucose sensor are important when applied in
vivo [246, 247]. The main function of an in vivo glucose sensor is to help
maintain near normoglycaemia in diabetic patients. Malfunction of the
sensor can have far-reaching consequences for the patient if glucose regula-
tion is based on the sensor measurements. Important sensor properties,
which can be determined in vitro, are the accuracy of measurement, sensi-
tivity of the sensor, the response time of the sensor and the stability of the
sensor. Chapter 3 describes a glucose measurement system (gms), the single
circulation system, which is based on the glucose sensor developed by
Schoonen and Schmidt. However, substantial changes have been made to
the flow system to minimise the leakage of enzyme from the gms. An
enzyme solution of god and catalase, used as perfusion fluid in the flow
system of Schoonen and Schmidt, is replaced by saline. The enzyme solu-
tion in this newly designed flow system, is retained in an enzyme reactor and
separated from the perfusion fluid by a semipermeable dialysis membrane.
A carbon filter is inserted in the perfusion flow to retain enzyme molecules
that leaked from the enzyme reactor and glucose eliminator. Consequently,
the in vitro characteristics of this system are different from the system devel-
oped by Schoonen and Schmidt. Therefore, this chapter describes experi-
ments designed to assess the in vitro characteristics of this newly designed
single circulation glucose measurement system (sc-gms). We determined
the accuracy of the sensor measurements, the sensor sensitivity for glucose,
the sensor response times, the influence of temperature on the sensor meas-
urements and the overall stability of the gms.75
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764.2 Materials and Methods
4.2.1 Experimental setup
For the determination of the various in vitro characteristics, the single cir-
culation glucose measurement system was used (n = 12). The separate flow
systems were assembled as described in chapter 2 and placed in the flow
system boxes. A personal computer (pc) was used to monitor the glucose
measurement systems during the different experiments. The flow system
boxes were coupled via an electric cable to a junction box (local electronic
workshop) which was connected to an a/d-converter (Daqbook). This
junction box contained eight connection sockets in combination with eight
potentiostats and pump control units. So in theory a maximum of eight sys-
tems could be tested simultaneously. In practice, however, maximally two
systems were tested at the same time due to the labour-intensive assembly
of the flow systems. The a/d-converter was connected to the pc for com-
munication with the sensor systems. The pc was used for storing the oxygen
electrode current, for setting the flow rate and the time interval of measure-
ment storage. The a/d-converter was needed to convert the analogous sig-
nals from the potentiostats and the pump units to digital signals so data could
be exchanged between the flow system boxes and the pc. Figure 4-1 gives
a schematic overview of the experimental set-up. 
The flow rate was set to 10µL/min. and the sample storage frequency for
most experiments to twice per minute. After a running-in period of 2 to 4
hours, during which the systems were tested on proper functioning, exper-
iments started.
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 Assessment of the accuracy of sensor measurements
The 12 systems were calibrated by placing the microdialysis probe at room
temperature (20 - 22 °C) in saline with different glucose concentrations (0,
1.4, 2.8, 4.2, 5.6, 6.9, 8.3, and 11.1 mM). During the day, one calibration
serie was made with every single system. In total, four calibration series were
made with every single system. The Saline-glucose solutions were gently
stirred to minimise the depletion of glucose from the layer of saline around
the dialysis tube. The separate sensors were calibrated by placing the probe
in alternately ascending or descending series of glucose concentrations
while the resulting oxygen electrode current was stored on the pc. The
linear response of the systems was determined by applying the anova F-
test (see also “Statistical analysis” on page 79). The slope of the regression
line in the linear measuring range were calculated from the separate calibra-
tion plots of the 12 sensors.
Figure 4-1. Schematic overview of experimental set-up.
 Assessment of the sensitivity (upper and lower detection limit)
Of 7 sensors the upper and lower detection limit were determined. For the
assessment of the lower detection limit, the microdialysis probe was placed












780.6, 0.8 and 1.1 mM. For the assessment of the upper detection limit saline-
glucose solutions of respectively 8.3, 11.1, 13.9, 19.4 and 22.2 mM were
used. The highest glucose concentration within the linear measuring range
of each system was taken as the upper detection limit of that system.
 Assessment of response times
Of 7 sensors the T90%, i.e. the time to reach 90% of the plateau value if a
sudden change in glucose concentration occurs, and the lag-time, i.e. the
time between the alteration of the glucose concentration and the sensor
reaction, was determined. The environment of the microdialysis probe was
changed from saline to a saline-glucose solution of 5.6 mM and vice versa.
Both T90% and lag-times were calculated from the calibration plots of each
7 sensors.
 Assessment of sensor stability
Two sensor systems were kept operational for 28 days at room temperatures
(20 - 22 °C). During this period base-line values (probe in saline) of both
sensors were recorded on the pc (30 measurements stored per hour). The
sensitivity of both sensor systems was determined by placing the microdial-
ysis probe regularly in a stirred 5.6 mM saline-glucose solution. The base-
line shift and the change in sensitivity for glucose of both systems during
this period were calculated using the sensor measurements. To assess the
influence of base-line shift of the separate oxygen electrodes on the total
base-line shift of the systems, the two electrodes were perfused with saline
for 28 days at room temperature while the output current was recorded (30
measurements stored per hour). For this purpose a perfusion system was
used that consisted of a micro-pump (Parker) which circulated saline, via the
oxygen electrode and oxygen permeable tubes (Teflon, Zeus Industrial
Products, i.d. 0.7 mm, o.d. 1.5 mm), at a flow rate of 10µL/min.
The effect of temperature changes on the sensor measurement at 0 mM glu-
cose was determined by placing 6 flow systems in an incubator (Model KBP
6087, Termacks, Kipp & Zonen, programmable temperature range: 0-70
°C). The temperature of the incubator during the temperature experiments
was increased from 5 °C to 35 °C in steps of 1.8 °C/hour.
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Results Statistical analysis
Data are reported as mean ± SD. The linear association between variables is
expressed by the Pearson’s product-moment correlation coefficient. To
assess whether the various glucose concentrations (mM) and the accompa-









), the anova F-test was performed. Of every batch of measure-
ments, the “lack of fit” F-value (Flof) and the inherent P-values of the sep-
arate regression lines were calculated. The P-values found indicate how well
the measured currents and presented glucose concentrations comply with a
linear relationship. When P-values equally or higher than 0.95 were found,
a linear relationship was assumed.
4.3 Results
 Accuracy of the sensor
The measurement series of four systems complied with a linear relation
(Table 4-1, p < 0.95, page 83). The calibration series of the remaining eight
systems showed a deviation of the linear model (Table 4-1, p < 0.95). The
current output of three systems did not change proportionally at glucose
concentrations higher than 8 mM (Table 4-1). The corresponding correla-
tion coefficients of the regression lines show that the output current of the
systems is reasonably correlated with the different glucose concentrations.
Base-line values of the oxygen electrodes used, i.e. at 0 mM glucose, are dif-
ferent for each system and range from 420 to 185 nA. The slopes of the cal-
ibration plots are different for each system. Figure 4-2 shows a typical in
vitro calibration plot of two of the systems in the range of 0 to 11.1 mM
(page 80). Figure 4-3 shows the corresponding response of one of these sys-
tems to glucose concentrations of 4.2 and 8.3 mM (page 80).
 Sensitivity and response time of the sensor
The lower detection limit of the 7 tested systems was 0.58 ± 0.15 mM. The
signal to noise ratio of most systems became too small for reliable measure-
ments when a glucose concentration of 0.28 mM was tested. The upper
detection limit of the systems was 14.3 ± 4.9 mM (n = 7).79
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80Figure 4-2. In vitro calibration plot of two glucose measurement systems.
Figure 4-3. Typical in vitro response of one of the glucose measurement
systems to glucose solutions of respectively 4.2 mM, 8.3 mM and 0 mM.
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ResultsFigure 4-4. Example of sensor response in vitro to changes in glucose
concentration (5.6 mM and 0 mM). For explanation of lag-time and T90%
see “Assessment of response times” on page 78.
The mean T90%-down of the 7 systems was 7.6 ± 0.9 min. and the T90%-
up 9.6 ± 1.5 min. By switching the microdialysis probe of each system from
saline to a saline-glucose solution of 5.6 mM and vice versa, lag-times of 1.5
± 0.4 min. and 1.8 ± 0.4 min. (n = 7) for respectively the descending and
ascending response curve, could be calculated. Figure 4-4 shows one of the
response curves made to assess the lag-times and T90%’s.
Time (min)





















82Figure 4-5. Base-line shift of one of the sensor systems during 28
days of continuous operation. Asterisks (*) indicate the sensor
response to a 5.6 mM glucose solution.
 Stability of the sensor
Figure 4-5 shows the measurements of one of the two systems during 28
days of continuous operation. The mean base-line shift of the two glucose
measurement systems during the 28 days is -0.98 ± 0.14%/24h. The mean
decline in sensitivity for glucose during this period was -0.79 ± 0.11%/24h
(n = 2). The mean base-line shift of the two oxygen electrodes during 28
days was -0.87 ± 0.1%/24h (n = 2).
 Temperature influence on sensor measurement
The increase in temperature by 1.8 °C/hour of 6 glucose measurement sys-
tems resulted in a linear increase in output current (Table 4-2). The mean
increase in output current was 4.7 ± 0.9 nA/°C.
Time (days)
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1 8.3 303 -21.1 -0.996 0.29 0.95 2.13 0.08 2.9
2 11.1 256 -12.0 -0.996 0.94 0.50 – – 2.0
3 11.1 420 -16.5 -0.999 1.37 0.27 – – 0.8
4 8.3 253 -22.8 -0.996 0.10 0.99 10.3 0.01 4.6
5 11.1 185 -10.9 -0.993 1.00 0.45 – – 4.1
6 11.1 199 -12.6 -0.998 0.84 0.56 – – 2.4
7 11.1 342 -25.2 -0.998 0.76 0.62 – – 3.5
8 8.3 335 -30.0 -0.999 0.24 0.95 2.58 0.04 2.4
9 11.1 301 -12.7 -0.984 0.82 0.58 – – 4.6
10 11.1 418 -31.9 -0.997 1.22 0.33 – – 4.5
11 11.1 209 -9.7 -0.984 0.39 0.99 – – 4.4
12 11.1 285 -16.1 -0.993 1.26 0.31 – – 3.8








A 115 268 5.1 0.999
B 130 277 4.9 0.998
C 187 295 3.6 0.999
D 243 429 6.2 0.998
E 194 329 4.5 0.999




 Assessment of the accuracy of sensor measurements
The in vitroexperiments done with the newly developed glucose measure-
ment system show that the system is suitable to measure glucose within a
defined glucose concentration range. The calibration data of four systems
illustrates that it is possible to have a good correlation between the output
current and the glucose concentration, although the mutual characteristics,
including the linear measuring range, differ for each system. The calibration
data of the remaining eight systems, however, show that the linear relation-
ship between the offered glucose concentrations and the output current is
not-significant (Table 4-1, p < 0.95). This can be explained by the influence
of additional parameters on the measurements. Because the calibration plots
were made on separate days, a combination of changes in air pressure, per-
fusion flow and electrode basal values may have contributed to deviations in
the separate calibration series during these days.
Nine of the tested systems gave a near linear response up to 11 mM glucose,
whereas of three systems the output current reached a plateau value at a glu-
cose concentration lower than 8 mM. This linear response of each system is
valid until the glucose concentration recovered in the microdialysis process
exceeds the actual concentration of dissolved oxygen present in the per-
fusion fluid. Also the detection range of the oxygen electrode influences the
linear measuring range.
At similar conditions, the basal current of the electrodes used in this study
varies considerably for each electrode. A higher basal current extends the
detection range of the electrode. These mutual differences are most likely a
result of the manual manufacturing process. For example, a larger platinum
cathode will increase the basal current relatively. The nominal disadvantage
of a higher basal electrode current is the accelerated consumption of elec-
trolyte, which shortens the total lifetime of the glucose sensor.
To expand the linear measuring range, the relative recovery has to be
reduced. This can be achieved by increasing the flow rate and/or by reduc-
ing the surface area of the dialysis tube. This is illustrated in equation 3.1
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Discussion(page 70) which describes the recovery by a microdialysis probe. Inherent
to a wider dynamic range is the loss in resolution because the detection
range of the oxygen electrode does not change. For in vivo studies in non-
diabetic human subjects, a linear measuring range of 0 to 11.1 mM glucose
is sufficient. In literature there has been some debate about the required
detection range in diabetic patients [73, 75]. The blood glucose concentra-
tion in “treated” diabetics can range from 1 up to 30 mM. Velho 	
 [73]
proposed that a linearity of response in the range of 1 to 15 mM would be
required for a glucose sensor. They argued that the upper limit of 15 mM
was sufficient high to be useful in the management of blood glucose levels.
Coming from normal levels, there would be enough time to avert too high
blood glucose levels. Kraeger and Chisholm [75] have suggested that a
sensor need only respond linearly up to 8 mM in “non-meal” periods. They
stated that the patient should inject insulin before meals and use the sensor
as an alarming device for too high blood glucose levels. However the general
opinion in the field is that a sensor should respond over the entire concen-
tration of 1 to 30 mM commonly observed in diabetics [74]. This means
that the range of our glucose measurement system has to be enlarged when
used in diabetic patients. One way to achieve this is by decreasing the size
of the dialysis membrane in the probe. At the same flow rate, the recovery
of glucose will be decreased [248] and thus result in a wider detection range.
The implied disadvantage will be the decrease in sensor sensitivity.
 Sensitivity of the sensor
The mean resolution of the tested systems is 0.58 mM. With smaller glucose
concentration differences it is not clear whether the response of the systems
is a result of the recovered glucose or due to the inherent noise of the sys-
tems. A longer dialysis tube and/or a lower perfusion rate will increase the
relative recovery and as a consequence, the resolution. However, it will also
decrease the linear measuring range and result in longer lag-times and
T90%’s if a lower perfusion rate is used. Depending on the intended in vivo
application, the relative recovery should be adjusted by changing the length
of the dialysis tube rather than increasing the perfusion flow. Halving the
length of the dialysis tube will result in twofold increase of the linear meas-
uring range (equation 3.1, page 70). An increase in perfusion flow, higher85
CHAPTER 4
Discussion
86than the 10 µL/min. used in the present experiments, may result in ultra-
filtration of perfusion fluid through the dialysis tube, affecting the recovery
of glucose.
 Assessment of response times
The system T90%-up/-down are higher than the T90% values Hashiguchi 	

 [69] and Laurell [68] found with their microdialysis based glucose meas-
urement systems (respectively 5.6/7.4 min. at flow rate 2 µL/min. and 2.0/
2.0 min. at flow rate 25 µL/min.). Found T90%-up/-down can, however, be
compared with the values reported by Keck 	
-T90%-up: 6.7 min. at flow
rate 10 µL/min. [228, 229].
The mean T90%-down of the tested systems is 2.4 times larger than the T90%
Schoonen & Schmidt found with their glucose measurement system -7.6
min. versus 3.1 min. [1]. Although the mean lag-time of both type of sys-
tems differ to some extent (1.5 min. versus 1 min.), the main cause for the
smaller T90% is that recovered glucose in the system of Schoonen and
Schmidt is converted immediately by god, which is dissolved in the per-
fusion fluid. In the newly developed system, however, recovered glucose has
to diffuse from the perfusion fluid into the enzyme reactor, before conver-
sion takes place. Consequently, at equal perfusion rates, higher values of
T90% will be found. The higher T90%-up of the tested systems can be
explained by the fact that after switching the dialysis probe from a glucose
concentration to saline, first all glucose present in the perfusion fluid has to
be converted and oxygen used in this conversion, has to be replenished.
The T90%’s and the lag-times can be reduced by increasing the flow rate
and reducing the total volume of the tubing, including the enzyme reactor,
between the dialysis tube and oxygen electrode. However, higher flow rates
and smaller tubing create a build-up of fluid pressure within the flow system
and can result in fluid “sweating” through the dialysis tube due to ultrafil-
tration. This disturbs the environment near the dialysis tube and results in
misinterpretation of measured glucose concentrations. Also the total length
of the tubing between the microdialysis tube and the oxygen electrode can
be shortened to improve the lag-time and T90% of the systems. Yet, for prac-
tical reasons, the length of the tubing can not be made too short without
giving in ease of use by the patient. This because the oxygen electrode is
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Discussionpositioned in the flow system box and there must be some flexibility
between the microdialysis probe, inserted in the tissue, and the flow system
box.
When a microdialysis system is designed, compromises have to be made.
On the one hand there is the wish of small delay times and on the other
hand there is the question of what is technically possible without undermin-
ing the reliability of the sensor measurements. So, an optimum has to be
found within the sensor design between these parameters.
Most important criterion is of course, how the T90%’s found relate to the
time parameters of physiological blood glucose concentration changes in
diabetic patients. Especially, a rapid fall in the blood glucose concentration
causes an acute danger. If the concentration falls below 2.6 mM it can result
in a hypoglycaemic coma of the patient. It is therefore essential that the
sensor is producing a distress signal (“hypo-alarm”) well in time. In this sit-
uation the relationship between decline rate in glucose concentration and
the sensor lag-time is a very important factor.
The rate of decline in blood glucose concentration will differ between
individuals. Aalders 	
 [235] observed in a study in type-1 diabetics, a
mean shift of 13 minutes between the venous blood glucose concentration
levels and the subcutaneous sensor levels when a rapid fall in the blood glu-
cose concentration was induced by the intravenous administration of insu-
lin. Hashiguchi 	
 found in a comparable in vivo study, a mean delay time
of 8.8 ± 1.6 minute [69]. It is therefore important that a distress signal is
already given at a glucose concentration higher than the critical glucose
concentration in vivo. This, to compensate for the total lag-time between
glucose change and corresponding sensor signal.
 Stability of the sensor and temperature influences
The overall in vitro stability of the systems mainly depends on the basal drift
of the oxygen electrodes as can be concluded when the mean basal drift of
the oxygen electrodes is compared to the mean basal drift of the complete
glucose measurement systems. Factors that also may influence the system
stability when glucose is measured are changes in the perfusion flow of the
microdialysis probe and the dialysis membrane permeability. The overall87
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88effect in time is a decrease in sensor sensitivity for glucose. The mean cali-
bration factor during this period changed by -0.95%/24h.
For reliable sensor functioning, measurements in time should be compen-
sated for the decrease in sensor sensitivity. The sensor measurement should
also be compensated for temperature changes. Increasing temperatures will
not only induce a diminution of oxygen solubility in the perfusion fluid but
also in higher diffusion rates across the Teflon membranes used in the elec-
trodes. The overall effect of temperature rise is an increase in output current
of 4.7 nA/°C.
In summary, the in vitro characteristics of the sc-gms presented here show
that it is possible to measure glucose reliably with the new designed flow sys-
tem. Although properties like dynamic range and resolution are system
dependent, it is very well possible to apply these systems in vivo after sepa-
rate calibration. Because it is the intention to use the system in diabetic
patients, widening of the linear measuring range to at least 30 mM is nec-
essary. The most suitable solution to expand the linear measuring range
would be by reducing the length of the dialysis tube in the probe. The in
vitro drift of the total system is acceptable to measure for measuring during
a period of at least 2 weeks. However, sensor measurements should be com-
pensated for temperature changes and the overall sensor drift in order to be
reliable.
